|
?:authorAffiliation
|
-
[\'Laboratory of Immunopathology Keizo Asami, Federal University of Pernambuco, Recife, PE, Brazil.\', \'Pronto Socorro Cardiológico de Pernambuco (PROCAPE), University of Pernambuco, Recife, PE, Brazil.\', \'University Hospital Oswaldo Cruz, University of Pernambuco, Recife, PE, Brazil.\', \'UNICAP Clinical Research Institute, Recife, PE, Brazil.\', \'CESMAC University Center/Heart Hospital of Alagoas, Maceió, AL, Brazil.\', \'Hypertension League, Federal University of Goiás, Goiânia, GO, Brazil.\', \'Cardiovascular Section, Geriatrics Division, Federal University of São Paulo, São Paulo, SP, Brazil.\', \'Department of Hypertension and Cardiometabolism, São Francisco Hospital - Santa Casa de Porto Alegre, Porto Alegre, Brazil.\', \'School of Medical Sciences, State University of Rio de Janeiro, Rio de Janeiro, RJ, Brazil.\', \'Department of Internal Medicine, School of Medical Sciences, State University of Campinas, SP Paulo, Brazil.\', \'Hypertension and Vascular Risk Unit, Department of Internal Medicine, Hospital Clínic, University of Barcelona, Barcelona, Spain.\', \'Laboratory of Immunopathology Keizo Asami, Federal University of Pernambuco, Recife, PE, Brazil. wilnj@fcm.unicamp.br.\', \'Department of Internal Medicine, School of Medical Sciences, State University of Campinas, SP Paulo, Brazil. wilnj@fcm.unicamp.br.\']
|
![[This page as RDF]](https://research.tib.eu/covid-19/static/rdf-icon.gif){kind=icon}